DMS Group Reports Q2 2026 Revenue of €12.2 Million

DMS Group, specializing in medical imaging systems, reported a Q2 2026 revenue of €12.2 million, marking a 4% decrease compared to the previous year. The company faced challenges in the radiology sector due to global economic conditions and delayed equipment deliveries to Ukraine. Despite this, there was a notable rebound in the Bone Densitometry sector, with Q2 revenue up by 32% following a prior decline.

For H1 2026, DMS Group's revenue stood at €22.1 million, down 6% from H1 2025. The drop is attributed to deferred contracts and cautious spending trends, particularly in Europe. However, DMS anticipates a stronger second half, expecting an ease in geopolitical tensions and better economic conditions.

DMS Group confirmed its 2026 guidance, aiming to outperform the market amid economic and geopolitical challenges. Growth is expected mainly from international markets, especially North America, supported by strategic partnerships.